| dc.identifier.citation | American Diabetes Asociation, 2016, Diabetes Type 1, Terdapat di:http://www.diabetes.org/diabetes- basics/type-1[Diakses pada 20 juni 2016]. Anderka O., Loenze P., Klabunde T., Dreyer M.K., Defossa E., Wendt K.U., and Schmoll D. 2008. Thermodynamic Characterization of Allosteric Glycogen Phosphorylase Inhibitors. Biochemistry 2008, 47, 4683–4691. Badan Penelitian dan Pengembangan Kesehatan Kementerian RI, 2013, Riset Kesehatan Dasar. Kitchen D.B., Decornez H., Furr J. D., & Bajorath J., 2004, Docking and scoring in virtual screening for drug discovery: methods and applications,Nature Reviews Drug Discovery, 3(11), 935–949. Lins L. and Brasseur R., 1995, The hydrophobic effect in protein folding,The FASEB J. 9(7): 535–540. Oikonomakos N.G., Schnier J.B., Zographos S.E., Skamnaki V.T., Tsitsanou K.E. and Johnson L.N., 2000, Flavopiridol Inhibits Glycogen Phosphorylase by Binding at the Inhibitor Site.J Biol Chem. 275 (44), 34566–34573. Santoso B., Haqqi M., Da‘i M., Hanwar D. and Suhendi A., 2016, Zerumbon dengan Protein Tyrosine Phosphatase 1B (PTP1B), 221–228. Setiawan F.F. and Istyastono E.P., 2015, Uji In Silico Senyawa 2,6-Dihidroksiantraquinon Sebagai Ligan Pada Reseptor Estrogen Alfa, Jurnal Farmasi Sains Dan Komunitas, Vol. 12 No. 2 hlm. 76-79. Syahputra G., 2014, Simulasi Docking Senyawa Kurkumin Dan Analognya Sebagai Inhibitor Enzim 12- Lipoksigenase,Tesis, IPB Bogor Indonesia. Yuniyati L., 2014, Pemodelan Tiga Dimensi (3d) Ikatan Hasil Docking Molekular Turunan Diketopiperazin (Dkp) DenganBcl-2 Pada Sel Mcf-7, Naskah Publikasi, Fakultas Farmasi, Universitas Muhammadiyah Surakarta, Surakarta. Sheinerman, F. B.; Giraud, E.; Laoui, A. 2005. High affinity targets of protein kinase inhibitors have similar residues at the positions energetically important for binding. J. Mol. Biol., 352, 1134-1156). Treadway JL, Mendys P, and Hoover DJ, 2005, Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus. Exp Opin Invest Drugs10:439–444 Ramya T. Sri, V. Sathyanathan, Kumar D. P., Chowdhari M, 2011, Docking Studies on Synthesizwd Quinazoline Compounds Against Androgen Receptor. Int. J. Pharm & Ind. Res 01 (04): 266 – 269. | in_ID |
| dc.description.abstract | nhibition of the enzyme glycogen phosphorylase which break down glycogen into glucose 1- phosphate (glycogenolysis) is a target in the treatment of type 2 diabetes milletus. Interaction mechanism between glycogen phosphorylase with flavopiridol studied with molecular docking method for efficiently. Molecular docking use a set of brand ACER laptop with Intel Core i3 processor, 2GB RAM and VGA Intel (R) HD Graphics 3000 operating system windows 7 32bit. Software PyRx-Autodock-Vina, Chimera, MarvinSketch, MarvinSpace, PyMOL and Protein Ligand Interaction Profiler (PLIP) were used. Molecular docking involves 1c8k target protein, active compound, 100 decoys compound from www.dekois.com, CPB native ligand, active compound that has been marketed, drug compounds c21h20CINO5 (UNII-DRP53ZDY6H), ROHITUKINE, RIVICICLIB, and C21H20CLNO4 (CHE48614). Docking results obtained from the four drug compounds that were tested had the ability molecular interactions better as glycogen phosphorylase inhibitor than the native ligand of the target protein 1C8K so that it can be further developed in the laboratory in vitro and in vivo, similarity between the nature of the native ligand ( 1c8k ) with best novel ( test ligand ) , when seen from the value of binding affinity zer on novel compounds showed greater potency than the native ligand as an antidiabetic | in_ID |
